Continuous glucose monitors have become popular among those who need to track their glucose levels because they're painless ...
A recent systematic review and meta-analysis published in Diabetes, Obesity and Metabolism in 2025 demonstrates that ...
The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...
Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration has cleared the first over-the-counter monitor that continuously checks glucose levels. The ...
Emerging research indeed suggests glucose monitors may offer benefits beyond insulin management, including improved glycemic ...
Heald, a digital metabolic health platform, today announced that consumers who purchase a Dexcom Stelo or Abbott Lingo continuous glucose monitor (CGM) through Heald will now receive complimentary ...
Morning Overview on MSN
The FDA cleared the first over-the-counter glucose monitor made for children
Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The ...
San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...
Over-the-counter continuous glucose monitors have gained popularity over recent years. These devices are designed to help people manage diabetes and other conditions that require monitoring of their ...
A quarter-size device that tracks the rise and fall of sugar in your blood is the latest source of hope — and hype — in the growing buzz around wearable health technology. Continuous glucose monitors, ...
For many years now, it has been rumored that the Apple Watch will eventually gain non-invasive blood sugar monitoring capabilities, which would enable millions of people with diabetes to track their ...
StockStory.org on MSN
Patient monitoring stocks Q1 results: Benchmarking DexCom (NASDAQ:DXCM)
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results